TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
GENinCode UK Ltd. ( (GB:GENI) ) has issued an announcement.
GENinCode Plc reported a 15% increase in revenue to £1.6m for the first half of 2025, driven by growth in the UK, EU, and US markets. Despite maintaining a steady gross profit margin of 53%, the company faced losses of £2.4m. The company is progressing with FDA De Novo discussions and advancing collaboration talks for test distribution in the US and EU. New clinical data on their CARDIO inCode-Score was presented at major cardiology conferences, highlighting its significance in cholesterol risk modulation for coronary heart disease.
The most recent analyst rating on (GB:GENI) stock is a Hold with a £1.50 price target. To see the full list of analyst forecasts on GENinCode UK Ltd. stock, see the GB:GENI Stock Forecast page.
Spark’s Take on GB:GENI Stock
According to Spark, TipRanks’ AI Analyst, GB:GENI is a Neutral.
GENinCode UK Ltd. faces significant financial challenges, with persistent losses and cash flow issues being the most critical factors. The technical analysis suggests a bearish trend, while the valuation is hampered by negative earnings. However, recent corporate events show positive strategic developments, which could support future growth.
To see Spark’s full report on GB:GENI stock, click here.
More about GENinCode UK Ltd.
GENinCode Plc is a UK-based company specializing in the prevention of cardiovascular disease and surveillance testing for ovarian cancer. It operates in the UK, Europe, and the United States, providing globally leading diagnostics and risk assessment for precision medicine treatment and preventive care. The company uses in vitro diagnostic molecular tests, clinical algorithms, and AI bioinformatics to advance patient risk assessment.
Average Trading Volume: 429,749
Technical Sentiment Signal: Sell
Current Market Cap: £4.02M
Learn more about GENI stock on TipRanks’ Stock Analysis page.